Skip to main content
Erschienen in: Pediatric Nephrology 7/2004

01.07.2004 | Original Article

The risk of cardiovascular disease in adults who have had childhood nephrotic syndrome

verfasst von: Brent Lee Lechner, Detlef Bockenhauer, Sandra Iragorri, Thomas Lyle Kennedy, Norman Joseph Siegel

Erschienen in: Pediatric Nephrology | Ausgabe 7/2004

Einloggen, um Zugang zu erhalten

Abstract

While increased risk of cardiovascular disease (CVD) in patients with hyperlipidemia, chronic kidney disease (CKD), or end-stage renal disease (ESRD) is well documented, transient hyperlipidemia or intermittent renal disease as a consequence of relapsing nephrotic syndrome (NS) has not been studied. To investigate this enigma, 62 patients, between 25 and 53 years of age, who had steroid-responsive/dependent NS during childhood, were identified from the records of the Division of Pediatric Nephrology at Yale School of Medicine. Forty patients were located and contacted to ascertain symptoms or occurrences of CVD via a telephone interview. At the time of follow-up, 23–46 years after cessation of NS, none of these patients had ESRD or CKD. Three patients had experienced a myocardial infarction (MI): a 32-year-old male with a family history of CVD; a 41-year-old male with a history of heavy smoking, hypertension, diabetes mellitus, and elevated cholesterol; a 31-year-old male after a cocaine overdose. The occurrence of events (8%) and mortality from CVD (none) in this cohort of patients is comparable to patients of a similar age in the general population and is lower than that of patients of the same age who are on dialysis. The data suggest that relapsing NS during childhood does not place patients at increased risk for CVD mortality or morbidity compared with the general population. Consequently, it would appear that factors related to persistent proteinuria or renal insufficiency, rather than transient proteinuria and renal disease, contribute to the CVD documented in patients with CKD or ESRD.
Literatur
1.
Zurück zum Zitat Churg J, Habib R, White RH (1970) Pathology of the nephrotic syndrome in children: a report for the International Study of Kidney Disease in Children. Lancet 760:1299–1302CrossRefPubMed Churg J, Habib R, White RH (1970) Pathology of the nephrotic syndrome in children: a report for the International Study of Kidney Disease in Children. Lancet 760:1299–1302CrossRefPubMed
2.
Zurück zum Zitat White RH, Glasgow EF, Mills RJ (1970) Clinicopathological study of nephrotic syndrome in childhood. Lancet I:1353–1359CrossRef White RH, Glasgow EF, Mills RJ (1970) Clinicopathological study of nephrotic syndrome in childhood. Lancet I:1353–1359CrossRef
3.
Zurück zum Zitat Roth KS, Amaker BH, Chan JC (2002) Nephrotic syndrome: pathogenesis and management. Pediatr Rev 23:237–248PubMed Roth KS, Amaker BH, Chan JC (2002) Nephrotic syndrome: pathogenesis and management. Pediatr Rev 23:237–248PubMed
4.
Zurück zum Zitat Tarshish P, Tobin JN, Bernstein J, Edelmann CM Jr (1997) Prognostic significance of the early course of minimal change nephrotic syndrome: report of the International Study of Kidney Disease in Children. J Am Soc Nephrol 8:769–776PubMed Tarshish P, Tobin JN, Bernstein J, Edelmann CM Jr (1997) Prognostic significance of the early course of minimal change nephrotic syndrome: report of the International Study of Kidney Disease in Children. J Am Soc Nephrol 8:769–776PubMed
5.
Zurück zum Zitat Bargman JM (1999) Management of minimal lesion glomerulonephritis: evidence-based recommendations. Kidney Int [Suppl] 70:S3–S16 Bargman JM (1999) Management of minimal lesion glomerulonephritis: evidence-based recommendations. Kidney Int [Suppl] 70:S3–S16
6.
Zurück zum Zitat Berns JS, Gaudio KM, Krassner LS, Anderson FP, Durante D, McDonald BM, Siegel NJ (1987) Steroid-responsive nephrotic syndrome of childhood: a long-term study of clinical course, histopathology, efficacy of cyclophosphamide therapy, and effects on growth. Am J Kidney Dis 9:108–114PubMed Berns JS, Gaudio KM, Krassner LS, Anderson FP, Durante D, McDonald BM, Siegel NJ (1987) Steroid-responsive nephrotic syndrome of childhood: a long-term study of clinical course, histopathology, efficacy of cyclophosphamide therapy, and effects on growth. Am J Kidney Dis 9:108–114PubMed
7.
Zurück zum Zitat Collins AJ (2003) Cardiovascular mortality in end-stage renal disease. Am J Med Sci 325:163–167CrossRefPubMed Collins AJ (2003) Cardiovascular mortality in end-stage renal disease. Am J Med Sci 325:163–167CrossRefPubMed
8.
Zurück zum Zitat Sarnak MJ, Levey AS (1999) Epidemiology of cardiac disease in dialysis patients. Semin Dial 12:69–76CrossRef Sarnak MJ, Levey AS (1999) Epidemiology of cardiac disease in dialysis patients. Semin Dial 12:69–76CrossRef
9.
Zurück zum Zitat Cornfeld D, Schwartz MW (1966) Nephrosis: a long-term study of children treated with corticosteroids. J Pediatr 68:507–515 Cornfeld D, Schwartz MW (1966) Nephrosis: a long-term study of children treated with corticosteroids. J Pediatr 68:507–515
10.
Zurück zum Zitat Abramowicz M, Barnett HL, Edelmann CM Jr, Greifer I, Kobayashi O, Arneil GC, Barron BA, Gordillo PG, Hallman N, Tiddens HA, (1970) Controlled trial of azathioprine in children with nephrotic syndrome. A report for the international study of kidney disease in children. Lancet I:959–961CrossRef Abramowicz M, Barnett HL, Edelmann CM Jr, Greifer I, Kobayashi O, Arneil GC, Barron BA, Gordillo PG, Hallman N, Tiddens HA, (1970) Controlled trial of azathioprine in children with nephrotic syndrome. A report for the international study of kidney disease in children. Lancet I:959–961CrossRef
11.
Zurück zum Zitat Fakhouri F, Bocquet N, Taupin P, Presne C, Gagnadoux MF, Landais P, Lesavre P, Chauveau D, Knebelmann B, Broyer M, Grunfeld JP, Niaudet P (2003) Steroid-sensitive nephrotic syndrome: from childhood to adulthood. Am J Kidney Dis 41:550–557CrossRefPubMed Fakhouri F, Bocquet N, Taupin P, Presne C, Gagnadoux MF, Landais P, Lesavre P, Chauveau D, Knebelmann B, Broyer M, Grunfeld JP, Niaudet P (2003) Steroid-sensitive nephrotic syndrome: from childhood to adulthood. Am J Kidney Dis 41:550–557CrossRefPubMed
12.
Zurück zum Zitat National Health Interview Survey (U.S.), National Center for Health Statistics (US) (2003) Summary health statistics for US children: National Health Interview Survey, 1999. National Center for Health Statistics, Hyattsville, Md., USA National Health Interview Survey (U.S.), National Center for Health Statistics (US) (2003) Summary health statistics for US children: National Health Interview Survey, 1999. National Center for Health Statistics, Hyattsville, Md., USA
13.
Zurück zum Zitat United States Renal Data System Annual Data Report (2000) National Institute of Diabetes and Digestive and Kidney Diseases (US), Division of Kidney Urologic and Hematologic Diseases, Urban Institute, Renal Research Program, University of Michigan, Bethseda, Md., USA United States Renal Data System Annual Data Report (2000) National Institute of Diabetes and Digestive and Kidney Diseases (US), Division of Kidney Urologic and Hematologic Diseases, Urban Institute, Renal Research Program, University of Michigan, Bethseda, Md., USA
14.
Zurück zum Zitat Jimi S, Uesugi N, Saku K, Itabe H, Zhang B, Arakawa K, Takebayashi S (1999) Possible induction of renal dysfunction in patients with lecithin:cholesterol acyltransferase deficiency by oxidized phosphatidylcholine in glomeruli. Arterioscler Thromb Vasc Biol 19:794–801PubMed Jimi S, Uesugi N, Saku K, Itabe H, Zhang B, Arakawa K, Takebayashi S (1999) Possible induction of renal dysfunction in patients with lecithin:cholesterol acyltransferase deficiency by oxidized phosphatidylcholine in glomeruli. Arterioscler Thromb Vasc Biol 19:794–801PubMed
15.
Zurück zum Zitat Saland JM, Ginsberg H, Fisher EA (2002) Dyslipidemia in pediatric renal disease: epidemiology, pathophysiology, and management. Curr Opin Pediatr 14:197–204CrossRefPubMed Saland JM, Ginsberg H, Fisher EA (2002) Dyslipidemia in pediatric renal disease: epidemiology, pathophysiology, and management. Curr Opin Pediatr 14:197–204CrossRefPubMed
16.
Zurück zum Zitat Querfeld U (1999) Should hyperlipidemia in children with the nephrotic syndrome be treated? Pediatr Nephrol 13:77–84CrossRefPubMed Querfeld U (1999) Should hyperlipidemia in children with the nephrotic syndrome be treated? Pediatr Nephrol 13:77–84CrossRefPubMed
17.
Zurück zum Zitat Sanjad SA, al-Abbad A, al-Shorafa S (1997) Management of hyperlipidemia in children with refractory nephrotic syndrome: the effect of statin therapy. J Pediatr 130:470–474PubMed Sanjad SA, al-Abbad A, al-Shorafa S (1997) Management of hyperlipidemia in children with refractory nephrotic syndrome: the effect of statin therapy. J Pediatr 130:470–474PubMed
18.
Zurück zum Zitat US Renal Data System Annual Data Report (2002) Altas of end-stage renal disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, Md., USA US Renal Data System Annual Data Report (2002) Altas of end-stage renal disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, Md., USA
Metadaten
Titel
The risk of cardiovascular disease in adults who have had childhood nephrotic syndrome
verfasst von
Brent Lee Lechner
Detlef Bockenhauer
Sandra Iragorri
Thomas Lyle Kennedy
Norman Joseph Siegel
Publikationsdatum
01.07.2004
Verlag
Springer-Verlag
Erschienen in
Pediatric Nephrology / Ausgabe 7/2004
Print ISSN: 0931-041X
Elektronische ISSN: 1432-198X
DOI
https://doi.org/10.1007/s00467-004-1460-x

Weitere Artikel der Ausgabe 7/2004

Pediatric Nephrology 7/2004 Zur Ausgabe

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.